1. Home
  2. Analysis
  3. Vytorin
  4. Vigamox

Vytorin and Vigamox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vytorin and Vigamox. Common interactions include therapeutic agent toxicity among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Vytorin and Vigamox have. It is created by eHealthMe based on reports of 25 people who take Vytorin and Vigamox from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

25 people who take Vytorin and Vigamox together, and have interactions are studied.

What is Vytorin?

Vytorin has active ingredients of ezetimibe; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 19,816 Vytorin users for its effectiveness, alternative drugs and more.

What is Vigamox?

Vigamox has active ingredients of moxifloxacin hydrochloride. It is often used in conjunctivitis. eHealthMe is studying from 2,659 Vigamox users for its effectiveness, alternative drugs and more.

Number of Vytorin and Vigamox reports submitted per year:

Vytorin and Vigamox drug interactions.

Common Vytorin and Vigamox drug interactions by gender *:

female:

  1. Therapeutic agent toxicity
  2. Angina pectoris
  3. Angioplasty
  4. Anxiety
  5. Arterial restenosis
  6. Arterial thrombosis limb
  7. Breath sounds
  8. Bundle branch block left
  9. Cardiac arrest
  10. Cardiomegaly

male:

  1. Chronic kidney disease
  2. Pancreatitis
  3. Acquired cardiac septal defect
  4. Anaemia
  5. Anxiety
  6. Apnoea
  7. Arteriosclerosis coronary artery
  8. Atelectasis
  9. Atrial fibrillation
  10. Atrial tachycardia

Common Vytorin and Vigamox drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pancreatitis
  2. Back pain
  3. Fall
  4. Chronic kidney disease
  5. Renal failure

50-59:

  1. Amnesia
  2. Balance disorder
  3. Eyeball rupture
  4. Fall
  5. Radius fracture
  6. Somnambulism
  7. Chronic kidney disease
  8. Diabetes mellitus
  9. Renal failure
  10. Renal injury

60+:

  1. Myocardial infarction
  2. Cardiac failure congestive
  3. Postoperative fever
  4. Anxiety
  5. Cardiac arrest
  6. Cardiomegaly
  7. Coronary artery disease
  8. Death
  9. Injury
  10. Myocardial ischaemia

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 32.00%
  2. Pain: 5 people, 20.00%
  3. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 5 people, 20.00%
  4. Insomnia (sleeplessness): 5 people, 20.00%
  5. Infection: 4 people, 16.00%
  6. Heart Rate Irregular: 3 people, 12.00%
  7. Neuralgia (pain in one or more nerves): 2 people, 8.00%
  8. High Blood Pressure: 2 people, 8.00%
  9. Diabetes: 2 people, 8.00%
  10. Depression: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vytorin and Vigamox?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Vytorin and Vigamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vytorin side effects:

Browse all side effects of Vytorin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vigamox side effects:

Browse all side effects of Vigamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vytorin interactions:

Browse all interactions between Vytorin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vigamox interactions:

Browse all interactions between Vigamox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe; simvastatin and moxifloxacin hydrochloride (the active ingredients of Vytorin and Vigamox, respectively), and Vytorin and Vigamox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Vytorin and Vigamox.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.